In the case of CCA, when CD36 expression levels are elevated, lipid uptake is subsequently increased, and the increased lipid content in turn facilitates the survival of CSCs in the tumor microenvironment (TME), ultimately increasing the risk of recurrence in patients. This evidence concerns the gene CD36 and cholangiocarcinoma.